Skip to content

formestane

โ† Previous: formebolone | ๐Ÿ  All Substances | ๐Ÿ“Š Complete Table | Next: formoterol โ†’

OPSS Properties

Classifications6000
DEA ScheduleSchedule III
ReasonControlled substance: Schedule III; WADA S4: Hormone and Metabolic ModulatorsUnapproved drug
Also Known As
  • 4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5ฮฑ-androstan-17ฮฒ-ol
  • 4-hydroxy-androst-4-ene-3,17-dione
  • 4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5alpha-androstan-17beta-ol
  • 4-hydroxy-ฮ”(sub 4)-androstenedione
  • 4-hydroxyandrost-4-ene-3,17-dione
  • 4-OH-A
  • CGP 32 349
  • 4-OHA
  • 4-hydroxyandrostenedione
  • 4-hydroxy-4-androstene-3,17-dione
  • Lentaron
  • CGP-32349
  • NSC 282175
  • CGP 32349
  • CCRIS 7483
  • 4-hydroxyandrostene-3,17-dione
  • 4-hydroxy-delta(sub 4)-androstenedione
  • BRN 1889793
Prohibited BecauseDEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III)
WADA S4: Hormone and Metabolic Modulators (WADA Prohibited List S4: Hormone and Metabolic Modulators)
Unapproved Drug
Added to DatabaseDecember 30, 2025
Source Last UpdatedFebruary 7, 2025
GUID3f512445-4025-4845-b757-a7b429df845b

References

External Resources

UNII: PUB9T8T355 ยท CAS: 566-48-3

PubChem Properties

Chemical Structure

Interactive 3D Structure

Molecular FormulaC19H26O3
Molecular Weight302.4 g/mol
IUPAC Name(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
InChIKeyOSVMTWJCGUFAOD-KZQROQTASA-N

๐Ÿ“Š Complete Table | ๐Ÿ  All Substances

Substance 424 of 880